Mild injectionsite reactions (redness, itching, transient discomfort) are the most common side effects reported in clinical trials [4] [6]
Peptide therapy often relies on this principle
Some people may have difficulty maintaining healthy B12 levels due to age, dietary patterns, digestive issues, certain medications, or absorption concerns
The leading edge of that market is driven by popular peptides in use by biohackers and longevity enthusiasts that range from the off-label use of GLP-1 agonists for Alzheimers prevention, to the newly FDA-approved mitochondrial therapeutic SS-31 (elamipretide), to popular grey market biohacker compounds like BPC-157 and Cerebrolysin
It is widely utilized in clinical settings outside the United States for treating stroke victims, traumatic brain injuries (TBI), and early-onset Alzheimer's disease
AI enhances personalized therapy through data integration across genomics, proteomics, metabolomics, and clinical records [231]